- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01023503
Observational Study To Evaluate Statins Patterns Of Use In Spain
July 23, 2013 updated by: AstraZeneca
Statins Use Patterns in Spain
The present project is aimed at describing the statins prescription pattern in Spanish patients.
It will also look into how adequate these prescriptions are accordingly to the recommendations given in Treatment Guidelines and in the Summary Product Information.
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
To be recruited by Primary Care Physicians
Description
Inclusion Criteria:
- Patients receiving a new statin prescription (naïve patients)
- Patients having a change in their statin prescription (dose, switching, addition to another hypolipemic drug)
Exclusion Criteria:
- Patients without enough information in the medical records to complete the fields required in the eCRF
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
1
Adults, with a new statin prescription or a change in their stain treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Current and previous hypolipemic treatment, dose and pattern
Time Frame: Retrospectively (information for the previous 6-months). Information collected once.
|
Retrospectively (information for the previous 6-months). Information collected once.
|
|
Statin treatment start date, origin of the prescription, reasons for changes in prescription
Time Frame: Retrospectively (information for the previous 6-months). Information collected once.
|
Retrospectively (information for the previous 6-months). Information collected once.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Socio-demographic characteristics
Time Frame: retrospectively
|
retrospectively
|
|
Total Cholesterol, HDL, LDL, Triglycerides, ALAT, Glucose, Creatine Kinase plasma levels
Time Frame: retrospectively
|
retrospectively
|
|
Concomitant Treatments and Cardiovascular History
Time Frame: retrospectively
|
retrospectively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (ANTICIPATED)
April 1, 2012
Study Completion (ANTICIPATED)
July 1, 2012
Study Registration Dates
First Submitted
October 31, 2009
First Submitted That Met QC Criteria
December 1, 2009
First Posted (ESTIMATE)
December 2, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
July 24, 2013
Last Update Submitted That Met QC Criteria
July 23, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIS-CES-CRE-2009/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.